GlassScriptPhysician profile
Mohamed Kazamel
NPI 1013144484
$15,048.06
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $5,880 · 2021: $8,278 · 2022: $125 · 2023: $254 · 2024: $390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $644.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $643.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $10,407.01 | 2020-2022 | |
| Akcea Therapeutics, INC. | $3,881.87 | 2019-2020 | |
| Boston Scientific Corporation | $254.22 | 2023 | Infinion 16, Artisan, Linear |
| Ucb, INC. | $134.05 | 2024 | |
| Alexion Pharmaceuticals, INC. | $131.53 | 2024 | |
| Csl Behring | $124.12 | 2024 | Hizentra |
| Mitsubishi Tanabe Pharma Development America, INC. | $115.26 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohamed Kazamel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.